Monthly Archives: September 2013

Home/2013/September

Pre-clinical proof-of-concept studies exploring schedules of administration of an adenovirus-based HBV immunotherapeutic show wide potential for induction of robust and long-lasting T-cell responses.

Houda Boukhebza, et al. Journal of Hepatology, 2013, (58), Supplement [...]

By |2019-07-03T12:12:48+02:00September 3rd, 2013|Publication, TG1050|Comments Off on Pre-clinical proof-of-concept studies exploring schedules of administration of an adenovirus-based HBV immunotherapeutic show wide potential for induction of robust and long-lasting T-cell responses.

130 – A multivalent adenovirus-based immunotherapeutic for treatment of chronic hepatitis B induces broad, robust and polyfunctional T cells in naive and HBV tolerant mice.

Perrine Martin, et al. Journal of Hepatology, 2013, (58), Supplement [...]

By |2019-07-03T12:18:43+02:00September 3rd, 2013|Publication, TG1050|Comments Off on 130 – A multivalent adenovirus-based immunotherapeutic for treatment of chronic hepatitis B induces broad, robust and polyfunctional T cells in naive and HBV tolerant mice.
Go to Top